Emmy and Tony award-winning actress and singer, Kristin Chenoweth will kick off Allergan’s “Less Red, More You” campaign at an exclusive event in New York City.
As part of the campaign, Chenoweth, who suffers from rosacea, will ignite a nationwide conversation about the typically underserved condition while raising awareness for Rhofadetm cream, a new product indicated for the topical treatment of persistent facial erythema associated with rosacea in adults.
Kristin Chenoweth Hosts RHOFADE™ (oxymetazoline HCl) cream, 1% Launch Event in NYC (PRNewsfoto/Allergan plc)
“As a performer who is constantly on stage or in front of the camera, it’s important that I take care of my skin, but unfortunately, persistent facial redness from rosacea is something I’ve struggled with every day for years,” said Chenoweth.
“Kristin is the perfect partner to help us increase awareness about this condition as she understands the daily challenges of living with rosacea,” said Jag Dosanjh, Senior Vice-President of Medical Dermatology at Allergan. “She is among the 16 million Americans who have rosacea, yet we know only a small fraction of that number is actually receiving treatment.
Allergan said that in two clinical trials, once-daily application of Rhofadetm cream was proven to reduce persistent facial erythema associated with rosacea through 12 hours on day 29. Results seen in 12%-18% of people using Rhofadetm cream vs 5%-9% of people using vehicle cream.